MOVING PHARMACEUTICAL COMPANIES FROM IMPROVED COMPLIANCE REPORTING TO CONTINUOUS IMPROVEMENT
 
BEST PRACTICES FOR SIMPLIFYING SPEND ANALYTICS AND OPTIMIZING
BUSINESS OPERATIONS
Pharmaceutical companies face increasingly complex compliance and reporting requirements as a result of the Physicians Payments Sunshine Act of the Affordable Care Act, more commonly referred to as Aggregate Spend. Violations of the rules can cost organizations from $10,000 to $100,000 per incident, and up to $1,000,000 per year. Such penalties can quickly accumulate if a company doesn't have the proper controls and agile reporting infrastructure in place.
 
Many companies are trying to meet these requirements using manual tools and processes, a time consuming, costly, and ultimately, highly inefficient approach. There is a better way.
 
CLICK HERE to download a whitepaper to find a better way.

321 Summer Street
Boston, MA 02210
United States

Unsubscribe